# Wavemaker Three-Sixty Health

Wavemaker Three-Sixty Health is a Private Equity based in Pasadena, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Pasadena, United States
- **Region:** North America
- **Address:** Pasadena, CA, United States
- **Founded:** 2018
- **Assets under management:** Undisclosed
- **Website:** wavemaker360.com
- **LinkedIn:** https://www.linkedin.com/company/wavemaker360

## Regulatory record

- **Reports private funds:** No

## About

Wavemaker Three-Sixty Health is the leading U.S. early-stage (Seed and following on at the Series A) venture capital fund focused 100% on healthcare. Wavemaker 360 invests in the most promising healthcare startups in North America, with LPs from every sector of the US healthcare system.

## Sectors

- Digital Health
- Healthcare Services
- Enterprise Software
- AI/ML

## People

- Jay Goss — General Partner
- Eric Marton — General Partner
- Dr. Steven Burrill — Venture Partner

## Questions

### Who runs investment decisions at Wavemaker Three-Sixty Health?

General Partners Jay Goss and Eric Marton lead the firm's investment committee. Goss was previously a managing director at a healthcare accelerator and brings operator experience in health tech startups. Marton has a background in corporate healthcare development. Dr. Steven Burrill joined as Venture Partner in 2022 and advises on portfolio strategy and healthcare system relationships, but final investment authority rests with the General Partners.

### How does Wavemaker Three-Sixty Health source its deals?

The firm relies on relationships within health system innovation centers, payer strategy groups, and clinical leadership networks rather than traditional accelerator demo-day pipelines. Its narrow mandate — exclusively enterprise health IT — means a high proportion of deals reach the firm through repeat co-investors and founder referrals from within its existing portfolio.

### Does Wavemaker Three-Sixty Health invest in life sciences or medical devices?

No. The firm explicitly limits its scope to digital health — software and AI-enabled services sold into healthcare enterprises. It does not invest in biotech, pharmaceutical development, medical devices, or diagnostics. This exclusion is structural, not circumstantial, and distinguishes it from hybrid health funds that allocate across both technology and life sciences.

### What is the firm's relationship to the wider Wavemaker Partners network?

Wavemaker Three-Sixty Health operates as a distinct, US-headquartered fund focused exclusively on healthcare IT, while Wavemaker Partners is a multi-sector venture firm with roots in Los Angeles and Singapore. The two share branding and some limited partner overlap, but the health fund makes its own investment decisions independently and maintains a separate portfolio.

## Related profiles

- [Wavemaker Partners](https://altss.com/profile/wavemaker-partners)
- [Waverley Capital](https://altss.com/profile/waverley-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/wavemaker-three-sixty-health

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology